Yasuhiro Ono
Fukuoka, 8310016, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Disease-specific signatures of circulating extracellular vesicles detected by the surface plasmon resonance imaging: a pilot study.
Journal: Extracellular vesicles and circulating nucleic acids
Published: October 22, 2024
Relationship of dietary intake and eating behaviors with glycemic control and body weight under long-term treatment with dapagliflozin: an exploratory prospective study.
Journal: Diabetology international
Published: August 22, 2024
Measurement of erythrocyte creatine might be useful for diagnosing latent hemolysis.
Journal: Clinical biochemistry
Published: November 30, 2021
A case of elderly myxedema coma patient with end-stage renal failure
Journal: Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
Published: February 25, 2021
TYK2 Promoter Variant Is Associated with Impaired Insulin Secretion and Lower Insulin Resistance in Japanese Type 2 Diabetes Patients.
Journal: Genes
Published: January 26, 2021
Effects of intensive exercise combined with dapagliflozin on body composition in patients with type 2 diabetes: a randomized controlled trial.
Journal: Endocrine journal
Published: January 04, 2021
Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 01, 2020
Estimation of the hemoglobin glycation rate constant.
Journal: Scientific reports
Published: July 04, 2020
HbA1c adjusted by erythrocyte creatine is a useful glycemic control indicator in patients with hemolysis.
Journal: Clinical biochemistry
Published: May 06, 2019
Shortened mean erythrocyte age in female patients with type 2 diabetes mellitus.
Journal: Journal of clinical laboratory analysis
Published: July 18, 2018
Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study.
Journal: Diabetology & metabolic syndrome
Published: August 05, 2016
Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes.
Journal: International scholarly research notices
Published: January 01, 2014
Last Updated: 09/26/2026